Protalix BioTherapeutics (PLX) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.61% |
| Dec 31, 2025 | 9.99% |
| Sep 30, 2025 | 0.17% |
| Jun 30, 2025 | 29.87% |
| Mar 31, 2025 | 6.55% |
| Sep 30, 2024 | 5.03% |
| Jun 30, 2024 | -1.39% |
| Mar 31, 2024 | -2.17% |
| Dec 31, 2023 | -8.97% |
| Sep 30, 2023 | -13.39% |
| Jun 30, 2023 | 11.21% |
| Mar 31, 2023 | -4.38% |
| Dec 31, 2022 | -19.67% |
| Sep 30, 2022 | -20.37% |
| Jun 30, 2022 | -18.40% |
| Mar 31, 2022 | -18.86% |
| Dec 31, 2021 | -9.23% |
| Sep 30, 2021 | -27.00% |
| Jun 30, 2021 | -9.11% |
| Mar 31, 2021 | -21.53% |
| Dec 31, 2020 | -64.41% |
| Sep 30, 2020 | -16.95% |
| Jun 30, 2020 | -35.46% |
| Mar 31, 2020 | -21.64% |
| Dec 31, 2019 | -20.14% |
| Mar 31, 2019 | -17.13% |
| Dec 31, 2018 | -15.24% |
| Sep 30, 2018 | -14.46% |
| Jun 30, 2018 | -3.08% |
| Mar 31, 2018 | -0.26% |
| Dec 31, 2017 | -0.34% |
| Sep 30, 2017 | -7.79% |
| Jun 30, 2017 | -10.24% |
| Mar 31, 2017 | 1.04% |
| Dec 31, 2016 | 18.57% |
| Sep 30, 2016 | 8.23% |
| Jun 30, 2016 | 4.40% |
| Mar 31, 2016 | 5.83% |
| Dec 31, 2015 | 16.30% |
| Sep 30, 2015 | -5.06% |
| Jun 30, 2015 | -4.68% |